NIR-PIT can also be used for programmed death-ligand 1 (PD-L1) expressing cancer cells [26], for CD25 for regulatory T cells (Tregs) [7,27,28], and CD44 [4,12,16,29,30] and CD133 for cancer stem cells [31]. This evidence concerns the gene IL2RA and cancer.